GlobeNewswire, Inc.

Search by
Stock Symbol

Email Alerts
If you like to receive future news releases distributed on Class Action Newsline, please register.

Law Firms
If your law firm would like to send news releases on the Class Action Newsline, please contact us.



Welcome to GlobeNewswire's Class Action Newsline. This Website is devoted to news and information related to class action lawsuits.

The Class Action Newsline contains the latest news from law firms and companies regarding class-action litigation and investigations, as well as responses from parties involved in the actions.

Individuals may register to receive future news releases distributed on Class Action Newsline. Law firms and other companies should contact us if they would like to send news releases on the Class Action Newsline.

Jul 2, 2009 22:39 Notice From the Securities Law Firm of Klayman & Toskes to All Former and Current BellSouth n/k/a AT&T Employees Who Maintained Accounts With Terry Barnhardt and Questar Capital Corp.
The Securities Law Firm of Klayman & Toskes ("K&T"), www.nasd-law.com, announced today that it filed an arbitration claim with the Financial Industry Regulatory Authority's ("FINRA") Office of Dispute Resolution against Questar Capital Corp. ("Questar"), for unsuitable investment recommendations and misrepresentations made by former Questar financial advisor Terry Barnhardt. Specifically, the Claimant has alleged that Mr. Barnhardt over-concentrated his account in securities that had exposure to the real estate market. Moreover, the Claimant has alleged that Mr. Barnhardt "guaranteed" these investments. However, it is a violation of NASD Rules for a broker to "guarantee" an investment. As a result of Mr. Barnhardt's unsuitable advice and misrepresentations, the Claimant sustained damages in excess of $400,000.   continued...

Jul 2, 2009 19:32 Levi & Korsinsky LLP Investigates Board of FCStone Group Inc.
Levi & Korsinsky ("L&K") is investigating the Board of Directors of FCStone Group Inc. ("FCStone" or the "Company") (Nasdaq:FCSX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to International Assets Holding Corp. (Nasdaq:IAAC) ("International Assets"). Under the terms of the agreement, FCStone shareholders will receive 0.2950 shares of International Assets stock for each share of FCStone they own. Based on the July 1, 2009 closing price of International Assets shares, the transaction is valued at $4.64 per share or approximately $130 million in the aggregate.   continued...

Jul 1, 2009 20:32 Keller Rohrback L.L.P. Announces ERISA Breach of Fiduciary Duty Investigation Regarding Austin Capital Management, Ltd.
Attorney Advertising. Keller Rohrback L.L.P (http://www.erisafraud.com) today announced that it is investigating Austin Capital Management, Ltd. ("Austin Capital") for potential violations of the Employee Retirement Income Security Act of 1974 ("ERISA"). The investigation focuses on retirement plans that have engaged Austin Capital to serve as its investment manager for its ERISA-qualified retirement plans.   continued...

Jul 1, 2009 11:57 Levi & Korsinsky LLP Investigates Board of Pamrapo Bancorp Inc.
Levi & Korsinsky ("L&K") is investigating the Board of Directors of Pamrapo Bancorp Inc. ("Pamrapo Bancorp" or the "Company") (Nasdaq:PBCI) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to BCB Bancorp, Inc. (Nasdaq:BCBP) ("BCB Bancorp"). Under the terms of the agreement, Pamrapo Bancorp shareholders will receive one share of BCB Bancorp for each share of Pamrapo Bancorp they own. Based on the June 29, 2009 closing price of BCB Bancorp shares, the transaction is valued at $9.50 per share or approximately $46.6 million in the aggregate.   continued...

Jun 30, 2009 18:56 Levi & Korsinsky LLP Investigates Board of First Advantage Corporation
Levi & Korsinsky ("L&K") is investigating the Board of Directors of First Advantage Corporation ("First Advantage" or the "Company") (Nasdaq:FADV) for possible breaches of fiduciary duty and other violations of state law in connection with a proposed sale of the Company to First American Corporation (NYSE:FAF) ("First American"). Under the terms of the proposal, First Advantage stockholders will receive 0.5375 shares of First American common stock for each share of the First Advantage they own. Based on the June 26, 2009 closing price of the common stock of First American, the proposed exchange ratio represents an offer price of $14.04 per First Advantage share.   continued...

Jun 30, 2009 14:59 Law Office of Brodsky & Smith, LLC Announces Investigation On Behalf of Shareholders of First Advantage Corp.
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of First Advantage Corp. ("First Advantage" or the "Company") (Nasdaq:FADV) related to the proposed merger with First American Corp. ("First American") (NYSE:FAF) in an all stock deal. First American has offered First Advantage shareholders $0.5375 a share for their stock. Based on First American's closing price on June 29, 2009, the deal is presently worth $13.84 a share for First Advantage holders. In addition to First American's significant representation on the Board of First Advantage due to owning approximately 75% of First Advantage's stock, the deal appears to be undervalued given the fact that as of June 29th, First Advantage stock was trading at over $15.00 a share, more than the current offer.   continued...

Jun 30, 2009 14:47 Law Office of Brodsky & Smith, LLC Announces Investigation on Behalf of Shareholders of Cell Genesys, Inc.
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cell Genesys, Inc. ("Cell Genesys" or the "Company") (Nasdaq:CEGE) related to the proposed merger with BioSante Pharmaceuticals, Inc. ("BioSante") (Nasdaq:BPAX) in an all stock deal. BioSante has offered Cell Genesys shareholders $0.1615 a share for their stock. Based on BioSante's closing price on June 29, 2009, the deal is presently worth $0.347 a share for Cell Genesys shareholders, with the total consideration being approximately $38 million. The deal appears to be unfair, in part, given the fact that since April 2009, Cell Genesys stock has traded at or above the offer price and as recently as May 2008 traded at over $0.68 a share. Moreover, the 200 day Moving Average on BioSante shares is only $1.75.   continued...

Jun 30, 2009 14:08 Holzer Holzer & Fistel, LLC Announces Investigation Into Purchase of Specialty Underwriters' Alliance of Illinois
Holzer Holzer & Fistel, LLC is investigating possible violations of law in connection with a proposed buyout of Specialty Underwriters' Alliance of Illinois ("Specialty Underwriters") (Nasdaq:SUAI) by Tower Group, Inc. (Nasdaq:TWGP) which was announced on June 22, 2009. The announcement indicated that Tower Group has agreed to exchange shares of its common stock for each outstanding share of Specialty Underwriters. The announcement states the conversion is equivalent to Tower Group paying approximately $6.72 per share of Specialty Underwriters' common stock.   continued...

Jun 30, 2009 12:29 Levi & Korsinsky LLP Investigates Board of Cell Genesys, Inc.
Levi & Korsinsky ("L&K") is investigating the Board of Directors of Cell Genesys, Inc. ("Cell Genesys" or the "Company") (Nasdaq:CEGE) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to BioSante Pharmaceuticals, Inc. (Nasdaq:BPAX) ("BioSante"). Under the terms of the agreement, Cell Genesys stockholders will receive 0.1615 shares of BioSante common stock in exchange for each common share of Cell Genesys. Based on the closing price of BioSante common stock on June 29, 2009, the transaction is valued at approximately $0.347 per share or a total consideration of approximately $38 million.   continued...

Jun 30, 2009 10:44 Finkelstein Thompson LLP Announces Investigation of First Advantage Corp. Proposed Merger
Finkelstein Thompson LLP is investigating potential shareholder claims arising from the proposed acquisition of First Advantage Corp. ("First Advantage" or the "Company") (Nasdaq:FADV) by First American Corp. ("First American") (NYSE:FAF). Under the terms of the proposed merger, First Advantage shareholders will receive 0.5375 of a share of First American common stock for each share of First Advantage common stock owned. This proposed exchange ratio represents an offer price of $14.04 per share based on both companies' closing prices on June 26, 2009.   continued...

More >>

Total: 10

* all times are in the U.S. Eastern Time Zone

 

GlobeNewswire | Class Action Newsline | Contact Us